Recent progress in dendrimer-based nanomedicine development

논문상세정보
    • 저자 김예진 박은지 나동희
    • 제어번호 106036349
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 41 No. 6 [ 2018 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 571-582 ( 12쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 영남대학교 중앙도서관 영남대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)

' Recent progress in dendrimer-based nanomedicine development' 의 참고문헌

  • Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers
    Chauhan AS [2009]
  • Tumor targeting using polyamidoamine dendrimer-cisplatin nanoparticles functionalized with diglycolamic acid and herceptin
    Kesavan A [2015]
  • Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes
    Lim LY [2015]
  • The structure and function of the hemagglutinin membrane glycoprotein of influenza virus
    Wiley DC [1987]
  • The role of nanotechnology in the treatment of viral infections
    Singh L [2017]
  • The present and the future of degradable dendrimers and derivatives in theranostics
    Leiro V [2015]
  • The influence of surface modification on the cytotoxicity of PAMAM dendrimers
  • The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel
    Jain NK [2015]
  • The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide
    Michiue H [2014]
  • Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
    Davignon JL [2013]
  • Targeting and inhibition of cell growth by an engineered dendritic nanodevice
    Thomas TP [2005]
  • Targeted nanosystems: advances in targeted dendrimers for cancer therapy
    Yang H [2016]
  • Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab
    Ma P [2015]
  • Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity
    Kim Y [2008]
  • Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers
    Zhang F [2016]
  • Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting
    Yang R [2016]
  • Study of interaction energies between the PAMAM dendrimer and nonsteroidal antiinflammatory drug using a distributed computational strategy and experimental analysis by ESI-MS/MS
  • Solubilization and anticancer-activity enhancement of Methotrexate by novel dendrimeric nanodevices synthesized in one-step reaction
  • Solubility enhancement of non-steroidal anti-inflammatory drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers
    Koc FE [2013]
  • Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy
    Wu G [2004]
  • Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis
  • SPL7013 Gel (<TEX>$VivaGel^{(R)}$</TEX> ) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans
    Price CF [2011]
  • Reducing agent-free synthesis of curcumin-loaded albumin nanoparticles by self-assembly at room temperature
    Safavi MS [2017]
  • Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
  • ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression
    Schumann C [2015]
  • RGDmodified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma
    Zhang L [2011]
  • Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers
    Landers JJ [2002]
  • Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent
    Zhang Y [2011]
  • Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
    Shaunak S [2004]
  • Polymer therapeutics and the EPR effect
    Maeda H [2017]
  • Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: recent trends and developments in HIV treatment/therapy
  • Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle
    Witvrouw M [2000]
  • Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery
    Kurtoglu YE [2009]
  • Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
    Esfand, R. [2001]
  • Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
  • Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-L-lysine dendrimers
  • Perspective: dendrimer drugs for infection and inflammation
    Shaunak S [2015]
  • Pegylated dendrimer and its effect in fluorouracil loading and release for enhancing antitumor activity
    Ly TU [2013]
  • Pathogen inhibition by multivalent ligand architectures
    Bhatia S [2016]
  • Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style
    Zhu S [2010]
  • PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
    He H [2011]
  • Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation
    Kulhari H [2015]
  • Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs)
    Chang Y [2011]
  • Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review
    Calixto GM [2016]
  • Nanostructured glycan architecture is important in the inhibition of influenza A virus infection
    Kwon SJ [2017]
  • Nanomedicines for treatment of viral diseases
    Mehendale R [2013]
  • Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?
    Nakamura Y [2016]
  • Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance
    Zheng W [2015]
  • Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells
    Matai I [2015]
  • Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects
    Son S [2015]
  • Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
    Zhang F [2016]
  • Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats
  • Methotrexate use in rheumatoid arthritis. A Clinician's perspective
    Alarcon GS [2000]
  • Mechanistic studies of viral entry: an overview of dendrimer-based microbicides as entry inhibitors against both HIV and HSV-2 overlapped infections
  • Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury
    Lei J [2017]
  • Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancer
    Wang Q [2015]
  • Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site
    Ryan GM [2017]
  • Large scale, green synthesis of a genenration-1 melamine (trazine) dendrimer
    Chouai A [2009]
  • Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
    Caster JM [2017]
  • Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells
  • Interactions between dendrimer biocides and bacterial membranes
    Chen CZ [2002]
  • Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers
    Reuter JD [1999]
  • Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers
    Kojima C [2010]
  • Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model
    Bahadoran A [2017]
  • In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles
    Durocher I [2016]
  • In situ-forming polyamidoamine dendrimer hydrogels with tunable properties prepared via aza-michael addition reaction
    Wang J [2017]
  • Impact of PAMAM delivery systems on signal transduction pathways in vivo: modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney
    Akhtar S [2016]
  • Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells
  • Highly sensitive dendrimer-based nanoplasmonic biosensor for drug allergy diagnosis
    Soler M [2015]
  • Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis
    Thomas TP [2011]
  • Folate receptor-targeted dendrimer-methotrexate conjugate for inflammatory arthritis
    Qi R [2015]
  • Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
    Mintzer MA [2012]
  • Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication
    Gong Y [2002]
  • Evaluations of unformulated and formulated dendrimerbased microbicide candidates in mouse and guinea pig models of genital herpes
  • Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
  • Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy
    Li N [2017]
  • Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications
    Kannan RM [2014]
  • Elegant pH-responsive nanovehicle for drug delivery based on triazine dendrimer modified magnetic nanoparticles
  • Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells
    Khatri S [2014]
  • Discovery of dendrimers and dendritic polymers: a brief historical perspective
    Tomalia DA [2002]
  • Difference in microchip electrophoretic mobility between partially and fully PEGylated poly(amidoamine) dendrimers
    Park EJ [2015]
  • Developing new antiviral agents for influenza treatment: what does the future hold?
    Hayden F [2009]
  • Designing dendrimers for biological applications
    Lee CC [2005]
  • Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors
    Barth RF [2016]
  • Design of interiorfunctionalized fully acetylated dendrimers for anticancer drug delivery
    Hu J [2011]
  • Design and synthesis of dendrimers with facile surface group functionalization, and an evaluation of their bactericidal efficacy
    Ladd E [2017]
  • Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor
    Quintana A [2002]
  • Dendrimers: properties and applications
    Klajnert B [2001]
  • Dendrimers: novel polymeric nanoarchitectures for solubility enhancement
    Gupta U [2006]
  • Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection
    Bourne N [2000]
  • Dendrimers to treat rheumatoid arthritis
    Bosch X [2011]
  • Dendrimers in photodynamic therapy
    Klajnert B [2012]
  • Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges
    Wu LP [2015]
  • Dendrimers in drug research
    Boas U [2004]
  • Dendrimers in biomedical applications-reflections on the field
    Svenson S [2005]
  • Dendrimers for theranostic applications
    Sk UH [2015]
  • Dendrimers as therapeutic agents: a systematic review
    Gajbhiye V [2009]
  • Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention
    McCarthy TD [2005]
  • Dendrimers as carriers for delivery of chemotherapeutic agents
    Medina SH [2009]
  • Dendrimers and their applications in immunoassays and clinical diagnostics
    Singh P [2007]
  • Dendrimer-protein interactions versus dendrimer-based nanomedicine
    Shcharbin D [2017]
  • Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
    Nance E [2017]
  • Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels
    Navath RS [2008]
  • Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface
    Choi SK [2013]
  • Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
    Menjoge AR [2010]
  • Dendrimer toxicity: let's meet the challenge
    Jain K [2010]
  • Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
    Sharma AK [2017]
  • Dendrimer biocompatibility and toxicity
    Duncan R [2005]
  • Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
    Teow HM [2013]
  • Delivery of MicroRNA-1 Inhibitor by dendrimerbased nanovector: an early targeting therapy for myocardial infarction in mice
    Xue X [2018]
  • Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform
    Huang B [2011]
  • Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice
    Abdoli A [2017]
  • Colony-stimulating factors in inflammation and autoimmunity
    Hamilton JA [2008]
  • Chromatographic methods for characterization of poly(ethylene glycol)-modified polyamidoamine dendrimers
    Park EJ [2014]
  • Carboxymethyl chitosan-modified polyamidoamine dendrimer enables progressive drug targeting of tumors via pH-sensitive charge inversion
    Qi X [2016]
  • Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy
    Barth RF [1994]
  • Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
    Capala J [1996]
  • Boron neutron capture therapy of cancer: current status and future prospects
    Barth RF [2005]
  • Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT
  • Bioreducible peptide-dendrimeric nanogels with abundant expanded voids for efficient drug entrapment and delivery
    Zhong D [2017]
  • Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio
    Zong H [2012]
  • Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation
  • Antibody–drug conjugates for targeted anticancer drug delivery
    김예진 [2016]
  • A poly(amidoamine) dendrimer-based drug carrier for delivering DOX to gliomas cells
    Li Y [2017]
  • A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis
    Hayder M [2011]
  • A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas
    Li Y [2012]
  • A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
    Jin Y [2011]
  • "Click" dendrimers as anti-inflammatory agents: with insights into their binding from molecular modeling studies
    Neibert K [2013]